GlassScriptPhysician profile
Timothy Gilbert Bazil
NPI 1760040034
$2,993.75
in general payments reported to CMS, 2019-2025
9 companies · $71.65 in 2025
The $71.65 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $2,478 · 2024: $444 · 2025: $71.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,498 · Travel and Lodging: $1,496.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,498.14 |
| Travel and Lodging | $1,495.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,050.16 | 2023 | Vanta Adaptivestim, Intellis Adaptivestim |
| Nevro Corp. | $485.54 | 2023-2024 | Senza |
| Vertos Medical, INC. | $167.35 | 2023 | Mild Device Kit |
| Nalu Medical, INC. | $128.42 | 2024 | Nalu Neurostimulation System |
| Abbvie INC. | $56.19 | 2024 | |
| Collegium Pharmaceutical, INC. | $33.36 | 2024-2025 | Belbuca |
| Globus Medical, INC. | $29.88 | 2025 | Vyrsa V1 |
| Janssen Biotech, INC. | $24.25 | 2025 | Tremfya |
| Boston Scientific Corporation | $18.60 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Bazil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.